The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2

被引:24
|
作者
Lai, Zon W. [1 ]
Lew, Rebecca A. [1 ]
Yarski, Michael A. [3 ]
Mu, Fi-Tjen [2 ]
Andrews, Robert K. [2 ]
Smith, A. Ian [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Peptide Biol Lab, Clayton, Vic 3800, Australia
[2] Monash Univ, Cardiovasc Biol Lab, Dept Immunol Alfred Med Res & Educ Precinct, Clayton, Vic 3800, Australia
[3] Baker Heart Res Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 3004, Australia
关键词
ANGIOTENSIN-CONVERTING-ENZYME-2; ACE2; CALCIUM-CHANNELS; GLYCOPROTEIN-VI; UP-REGULATION; CARBOXYPEPTIDASE; HOMOLOG; CELLS; RECOGNITION; EXPRESSION; LIVER;
D O I
10.1210/en.2008-1274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-converting enzyme (ACE)-2 is a homolog of the well-characterized plasma membrane-bound angiotensin-converting enzyme. ACE2 is thought to play a critical role in regulating heart function, and in 2003, ACE2 was identified as a functional receptor for severe acute respiratory syndrome coronavirus. We have recently shown that like ACE, ACE2 undergoes ectodomain shedding and that this shedding event is up-regulated by phorbol esters. In the present study, we used gel shift assays to demonstrate that calmodulin, an intracellular calcium-binding protein implicated in the regulation of other ectodomain shedding events, binds a 16-amino acid synthetic peptide corresponding to residues 762-777 within the cytoplasmic domain of human ACE2, forming a calcium-dependent calmodulin-peptide complex. Furthermore, we have demonstrated that ACE2 expressed in Chinese hamster ovary cells specifically binds to glutathione-S-transferase-calmodulin, but not glutathione-S-transferase alone, in pull-down assays using cell lysates. Finally, to investigate whether calmodulin has any effect on ACE2 ectodomain shedding in cells that endogenously express the enzyme, cells from a human liver cell line (Huh-7) expressing ACE2 were incubated with calmodulin-specific inhibitors, trifluoperazine and calmidazolium. Both trifluoperazine (25 mu mol/liter) and calmidazolium, (25 mu mol/liter) significantly increased the release of ACE2 into the medium (44.1 +/- 10.8%, P < 0.05, Student's t test; unpaired, two-tailed, and 51.1 +/- 7.4% P < 0.05, one-way ANOVA, respectively;), as analyzed by an ACE2-specific quenched fluorescence substrate assay. We also show that the calmodulin-specific inhibitor-stimulated shedding of ACE2 is independent from phorbol ester-induced shedding. In summary, we have demonstrated that calmodulin is able to bind ACE2 and suggest that the ACE2 ectodomain shedding and/or sheddase(s) activation regulated by calmodulin is independent from the phorbol ester-induced shedding. (Endocrinology 150: 2376-2381, 2009)
引用
收藏
页码:2376 / 2381
页数:6
相关论文
共 50 条
  • [21] Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
    Subhomoi Borkotoky
    Debajit Dey
    Zaved Hazarika
    Molecular Biology Reports, 2023, 50 : 2713 - 2721
  • [22] Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
    Borkotoky, Subhomoi
    Dey, Debajit
    Hazarika, Zaved
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (03) : 2713 - 2721
  • [23] Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy
    Batlle, Daniel
    Wysocki, Jan
    Soler, Maria J.
    Ranganath, Keerthi
    KIDNEY INTERNATIONAL, 2012, 81 (06) : 520 - 528
  • [24] The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences
    Maranduca, Minela Aida
    Tanase, Daniela Maria
    Cozma, Cristian Tudor
    Dima, Nicoleta
    Clim, Andreea
    Pinzariu, Alin Constantin
    Serban, Dragomir Nicolae
    Serban, Ionela Lacramioara
    PHARMACEUTICS, 2022, 14 (09)
  • [25] Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean
    Takahashi, Saori
    Yoshiya, Taku
    Yoshizawa-Kumagaye, Kumiko
    Sugiyama, Toshihiro
    BIOMEDICAL RESEARCH-TOKYO, 2015, 36 (03): : 219 - 224
  • [26] Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
    Mitani, Sawane
    Yabuki, Akira
    Sawa, Mariko
    Chang, Hye-Sook
    Yamato, Osamu
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2014, 76 (01) : 45 - 50
  • [27] Conversion of Aβ43 to Aβ40 by the Successive Action of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme
    Liu, Shuyu
    Liu, Junjun
    Miura, Yukie
    Tanabe, Chiaki
    Maeda, Tomoji
    Terayama, Yasuo
    Turner, Anthony J.
    Zou, Kun
    Komano, Hiroto
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (09) : 1178 - 1186
  • [28] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230
  • [29] Angiotensin-converting enzyme 2: a key enzyme in key organs
    Pagliaro, Pasquale
    Thairi, Cecilia
    Alloatti, Giuseppe
    Penna, Claudia
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (01) : 1 - 11
  • [30] Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike
    Kehinde, Idowu A.
    Egbeyemi, Anu
    Kaur, Manvir
    Onyenaka, Collins
    Adebusuyi, Tolulope
    Olaleye, Omonike A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (07) : 2992 - 3001